#37 – A Gab about Cab: The Short on Long-Acting Antiretrovirals for HIV

Dr. Fidelia Bernice, Dr. Rodrigo Burgos, and Dr. Neha Pandit, join Breakpoints to discuss the first available long-acting antiretroviral agent, cabotegravir/rilpivirine. Learn more about the Society of Infectious Diseases Pharmacists: https://sidp.org/About Twitter: @SIDPharm (https://twitter.com/SIDPharm) Instagram: @SIDPharm (https://www.instagram.com/sidpharm/) Facebook: https://www.facebook.com/sidprx LinkedIn: https://www.linkedin.com/company/sidp/

Episode metadata supplied by the publisher feed · Published Apr 16, 2021

Embed this episode

Attribution link and audio player

Ready to play

#37 – A Gab about Cab: The Short on Long-Acting Antiretrovirals for HIV

0:00 32:10

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Breakpoints?

This episode is 32 minutes long.

When was this Breakpoints episode published?

This episode was published on April 16, 2021.

Can I download this Breakpoints episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!